publication venue for
- Heterogeneity and origins of myeloid cells. 2022
- Erythroid cells and malaria parasites: it's a match! 2021
- Driver mutations in acute myeloid leukemia. 2020
- Recent advances in allogeneic hematopoietic cell transplantation for acute myeloid leukemia. 2020
- Transfusion support and alternatives for Jehovah's Witness patients. 2019
- Hematopoietic-cell transplantation for lymphoma in the era of genetically engineered cellular therapy: it's not quite time to scrap the old vehicle for the new car. 2019
- Role of chromosomal architecture in germinal center B cells and lymphomagenesis. 2019
- Using genomic data for selecting the treatment of lymphoma patients. 2019
- Strategies for managing transfusional iron overload: conventional treatments and novel strategies. 2019
- Cohesin mutations in myeloid malignancies made simple. 2018
- New therapeutic strategies for high-risk acute myeloid leukemia. 2018
- Patient-derived tumor xenografts of lymphoproliferative disorders: are they surrogates for the human disease? 2017
- Regulation of the hematopoietic stem cell lifecycle by the endothelial niche. 2017
- The new frontier of epigenetic heterogeneity in B-cell neoplasms. 2017
- Can any patients with chronic myeloid leukemia outside of a clinical trial have their tyrosine kinase inhibitor discontinued? 2017
- Genetic and epigenetic determinants of B-cell lymphoma evolution. 2016
- Histiocytic neoplasms in the era of personalized genomic medicine. 2016
- The many layers of epigenetic dysfunction in B-cell lymphomas. 2016
- Hairy cell leukemia: update and current therapeutic approach. 2015
- Allogeneic haematopoietic stem cell transplantation for primary myelofibrosis and myelofibrosis evolved from other myeloproliferative neoplasms. 2015
- Clinical and molecular genetic characterization of myelofibrosis. 2015
- Mixed lineage rearranged leukaemia: pathogenesis and targeting DOT1L. 2015
- How do viruses trick B cells into becoming lymphomas? 2014
- Iron chelation: an update. 2014
- Pathogenesis and management of acute myeloid leukemia that has evolved from a myeloproliferative neoplasm. 2014
- Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma. 2013
- The metabolism of lymphomas. 2013
- Fibroblast growth factor signaling promotes physiological bone remodeling and stem cell self-renewal. 2013
- Thrombopoietin-receptor agonists. 2012
- Genetic mutations in chronic myelogenous leukemia: when to check and what to do? 2012
- Epigenetics and B-cell lymphoma. 2011
- Genetics of the myeloproliferative neoplasms. 2011
- Spectrum of HIV lymphoma 2009. 2010
- Appropriate sequencing of tyrosine kinase inhibitors in chronic myelogenous leukemia: when to change? A perspective in 2009. 2009
- B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma. 2008
- Immune thrombocytopenic purpura in adults. 2007
- New therapies for immune thrombocytopenic purpura. 2007
- JAK-2 mutations and their relevance to myeloproliferative disease. 2007
- Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. 2006
- Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia. 2006
- Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases. 2003
- Histone deacetylases as therapeutic targets in hematologic malignancies. 2002
- Molecular mechanisms of resistance to STI571 in chronic myeloid leukemia. 2002
- Issues in the manufacture and transplantation of genetically modified hematopoietic stem cells. 2000
- Advances in immunotherapy of hematologic malignancies: cellular and humoral approaches. 2000
- Advances in the treatment of Hodgkin's lymphoma. 2000
- Recent advances in the treatment of acute leukemia: 1999. 2000
- Radionuclides as conditioning before stem cell transplantation. 1999
- Dendritic cells: expansion and differentiation with hematopoietic growth factors. 1999
- Interleukin-5 and the regulation of eosinophil production. 1999
- Recent advances in the treatment of acute leukemia. 1997
- Management of thrombocythemia. 1996
- Calcium and signal transduction in granulocytes. 1996
- Changing concepts in fibrinolysis. 1995
- Specific genetic defects as targets for selective therapies. Commentary. 1994